Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

DO WE REALLY NEED NEW AMINOGLYCOSIDES?

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    DO WE REALLY NEED NEW AMINOGLYCOSIDES?. Inpharma Wkly. 57, 3 (1976). https://doi.org/10.1007/BF03288848

    Download citation

    Keywords

    • Gentamicin
    • Kanamycin
    • AMINOGL YCOSIDES
    • Hepatic Encephalopathy
    • Neomycin